Related content

Comments on: ‘Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease – a randomized controlled trial’

By  

EUROPEAN JOURNAL OF NEUROLOGY, Vol. 25, Iss. 1, 2018-01 ,pp. : e4-e4

John Wiley & Sons Inc

Access to resources Recommend Favorite

Droxidopa for the Short‐Term Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Parkinson's Disease (nOH306B)

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 5, 2015-04 ,pp. : 646-654

John Wiley & Sons Inc

Access to resources Recommend Favorite

Vitamin D deficiency in Parkinson's disease patients with orthostatic hypotension

By  

ACTA NEUROLOGICA SCANDINAVICA (ELECTRONIC), Vol. 132, Iss. 4, 2015-10 ,pp. : 242-250

John Wiley & Sons Inc

Access to resources Recommend Favorite

Orthostatic Hypotension in Parkinson Disease: How Much You Fall or How Low You Go?

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 5, 2015-04 ,pp. : 639-645

John Wiley & Sons Inc

Access to resources Recommend Favorite

Orthostatic hypotension in older patients

By  

Reviews in Clinical Gerontology, Vol. 17, Iss. 4, 2007-11 ,pp. : 259-275

Cambridge University Press

Access to resources Recommend Favorite